Galera shares double after firm announces 'corrected' study results for its lead drug candidate
December 14, 2021 at 13:06 PM EST
An "error" in previously released results sent the company's stock price down by more than 70% in October.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|